The 8-week, Prospective, Randomized Controlled of IntraDermal Administration of Comirnaty 6 Microgram Versus Intramuscular Comirnaty 30 Microgram by 28 Days Interval Efficacy Study in Healthy Volunteer
Latest Information Update: 20 May 2022
At a glance
- Drugs Tozinameran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- Acronyms PRIDE
Most Recent Events
- 05 May 2022 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 06 Sep 2021 New trial record